[1]
S. Dari, F. Verginelli, and S. Aquilani, “Pharmacoeconomic aspects related to the 13-valent pneumococcal conjugate vaccine: preliminary analysis of the data from the ASL of Viterbo”, FE, vol. 15, no. 4, pp. 155–159, Dec. 2014.